{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-000048","form_type":"8-K","ticker":"FLGT","cik":"0001674930","company_name":"Fulgent Genetics, Inc.","filed_at":"2023-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.097702+00:00","generated_at":"2026-06-20T20:55:45.491980+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Fulgent Genetics appoints Reggie Groves to board, cures Nasdaq audit committee deficiency","bullets":["Reggie Groves appointed to Fulgent Board effective Jan 3, 2023; serves on Audit, Compensation, and Nominating/Governance committees.","Appointment resolves non-compliance with Nasdaq Rule 5605 requiring three independent directors on Audit Committee (disclosed Nov 18, 2022).","Groves brings 13 years at Medtronic and experience as CFO/COO at Stimwave, CEO at REVA Medical, and board service at AtriCure.","Groves will receive standard compensation per Non-Employee Director Compensation Policy and entered indemnification agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-000048","json":"https://secwatch.observer/filing/0000950170-23-000048.json","markdown":"https://secwatch.observer/filing/0000950170-23-000048.md","text":"https://secwatch.observer/filing/0000950170-23-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674930/000095017023000048/0000950170-23-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674930/000095017023000048/flgt-20230103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T20:55:45.491980+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4bb78f0a3c","claim":"Regina Groves was appointed as Director at Fulgent Genetics, Inc..","evidence_excerpt":"On January 3, 2023, the Board of Directors (the “Board”) of the Fulgent Genetics, Inc. (the “Company”) appointed Ms. Regina (“Reggie”) Groves to serve as a member of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1674930/000095017023000048/0000950170-23-000048-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}